| Dr Antonella Bollettino Fine, MD | |
|
211 Park St., Sturdy Memorial Hospital Department Of Medicine, Attleboro, MA 02703-0963 | |
| (508) 236-7909 | |
| Not Available |
| Full Name | Dr Antonella Bollettino Fine |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 13 Years |
| Location | 211 Park St., Attleboro, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679866727 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sturdy Memorial Hospital | Attleboro, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sturdy Memorial Hospital Inc | 4981653789 | 42 |
News Archive
Genentech, a member of the Roche Group, today announced positive results from the Phase III IMpower130 study of Tecentriq (atezolizumab) plus chemotherapy (carboplatin and Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of people with previously untreated metastatic non-squamous non-small cell lung cancer.
The search to discover and validate the first-ever clinical biomarker to diagnose and treat pancreatic cancer is at the foundation of a new, cross-sector collaboration. Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological research approach; the Cancer Center at Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital, and the Pancreatic Cancer Research Team managed by Cancer Research And Biostatistics announced today they will work together to eradicate the disease.
MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it has been granted U.S. patent No. 7,824,588 from the United States Patent and Trademark Office (USPTO). The patent, issued on November 2, 2010, provides intellectual property protection for the Company's film products and methods of their preparation.
Alzheimer's disease has been linked in many studies to amyloid plaque buildup in the brain, but new research is finding a common thread between amyloid burden and lower energy levels, or metabolism, of neurons in certain areas of the brain associated with Alzheimer's disease-even for people with no sign of cognitive decline.
› Verified 8 days ago
| Entity Name | Sturdy Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730106162 PECOS PAC ID: 4981653789 Enrollment ID: O20050119000678 |
News Archive
Genentech, a member of the Roche Group, today announced positive results from the Phase III IMpower130 study of Tecentriq (atezolizumab) plus chemotherapy (carboplatin and Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of people with previously untreated metastatic non-squamous non-small cell lung cancer.
The search to discover and validate the first-ever clinical biomarker to diagnose and treat pancreatic cancer is at the foundation of a new, cross-sector collaboration. Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological research approach; the Cancer Center at Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital, and the Pancreatic Cancer Research Team managed by Cancer Research And Biostatistics announced today they will work together to eradicate the disease.
MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it has been granted U.S. patent No. 7,824,588 from the United States Patent and Trademark Office (USPTO). The patent, issued on November 2, 2010, provides intellectual property protection for the Company's film products and methods of their preparation.
Alzheimer's disease has been linked in many studies to amyloid plaque buildup in the brain, but new research is finding a common thread between amyloid burden and lower energy levels, or metabolism, of neurons in certain areas of the brain associated with Alzheimer's disease-even for people with no sign of cognitive decline.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Antonella Bollettino Fine, MD 211 Park St., P.o. Box 2963, Sturdy Memorial Hospital Department Of Medicine, Attleboro, MA 02703-0963 Ph: (508) 236-7909 | Dr Antonella Bollettino Fine, MD 211 Park St., Sturdy Memorial Hospital Department Of Medicine, Attleboro, MA 02703-0963 Ph: (508) 236-7909 |
News Archive
Genentech, a member of the Roche Group, today announced positive results from the Phase III IMpower130 study of Tecentriq (atezolizumab) plus chemotherapy (carboplatin and Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of people with previously untreated metastatic non-squamous non-small cell lung cancer.
The search to discover and validate the first-ever clinical biomarker to diagnose and treat pancreatic cancer is at the foundation of a new, cross-sector collaboration. Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological research approach; the Cancer Center at Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital, and the Pancreatic Cancer Research Team managed by Cancer Research And Biostatistics announced today they will work together to eradicate the disease.
MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it has been granted U.S. patent No. 7,824,588 from the United States Patent and Trademark Office (USPTO). The patent, issued on November 2, 2010, provides intellectual property protection for the Company's film products and methods of their preparation.
Alzheimer's disease has been linked in many studies to amyloid plaque buildup in the brain, but new research is finding a common thread between amyloid burden and lower energy levels, or metabolism, of neurons in certain areas of the brain associated with Alzheimer's disease-even for people with no sign of cognitive decline.
› Verified 8 days ago
Asma Latif, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 19 Sturdy St, Attleboro, MA 02703 Phone: 508-236-8525 Fax: 508-342-1927 | |
Dr. Prabhu Sudantiraraj Ram, M.D Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 19 Sturdy St, Attleboro, MA 02703 Phone: 508-236-8360 Fax: 508-236-8377 | |
Raymond D. Petit, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 159 Pleasant St, Attleboro, MA 02703 Phone: 508-226-0213 Fax: 508-226-6820 | |
Steven A Bensson, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 28 Sturdy St, Attleboro, MA 02703 Phone: 508-236-8360 Fax: 508-222-8075 | |
Dr. Mark A Robbin, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 150 Emory St, Attleboro, MA 02703 Phone: 508-222-2021 Fax: 508-226-0134 | |
Lawrence Dwight Barr, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: Sturdy Memorial Hospital, 211 Park Street, Attleboro, MA 02703 Phone: 508-236-7600 | |
Dr. Meghan Banik Sass, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 159 Pleasant St, Attleboro, MA 02703 Phone: 508-226-0213 |